Is Fluidra (BME:FDR) Offering Value After Recent Share Price Pullback?

• This article examines whether Fluidra at €19.23 is a bargain or fairly priced by exploring what the current market is implying about the stock's value.
• The share price has seen mixed returns, with a 3.3% decline over the last 7 days and a 10.0% decline over the past month, while the 3-year return sits at 22.9% and the 5-year return at a 31.4% decline.
• Recent coverage has focused on how Fluidra's share price performance compares with the broader machinery sector and how investor expectations around demand for pool and wellness products may be influencing sentiment. Other commentary has highlighted how the current share price and recent pullback could be affecting views on whether the stock still fits long-term investment plans.
• On Simply Wall St's valuation checks, Fluidra scores 5 out of 6. The rest of this article will outline what different valuation approaches indicate about that score, and then conclude with a broader way to think about whether the market price makes sense for you.

Find out why Fluidra's -3.5% return over the last year is lagging behind its peers.

Approach 1: Fluidra Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a stock might be worth by projecting future cash flows and then discounting them back to today using a required return. It is essentially asking what Fluidra's future cash generation could be worth in today's euros.

Fluidra's latest twelve month Free Cash Flow is about €271.2 million. Analysts and extrapolated estimates used in the 2 Stage Free Cash Flow to Equity model point to projected Free Cash Flow of €409.0 million in 2030, with a set of yearly projections between now and 2035 that are then discounted back to today. All of these figures are in € and remain below €1b, so they are considered in millions rather than billions.

Putting these cash flows together gives an estimated intrinsic value of €26.43 per share. Compared with the current share price of €19.23, the model implies a 27.2% discount. On this DCF view, the stock screens as undervalued.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Fluidra is undervalued by 27.2%. Track this in your watchlist or portfolio, or discover 227 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Fluidra.

Approach 2: Fluidra Price vs Earnings

For profitable companies, the P/E ratio is a useful way to see how much you are paying for each euro of current earnings, which makes it a straightforward cross check against the cash flow based DCF result.

What counts as a “normal” P/E depends on what investors expect for future growth and how much risk they see in those earnings. Higher growth and lower perceived risk often justify a higher P/E, while slower growth or higher risk usually line up with a lower multiple.

Fluidra currently trades on a P/E of 20.7x, compared with a Machinery industry average of 25.8x and a peer group average of 12.5x. Simply Wall St also calculates a proprietary “Fair Ratio” of 28.2x for Fluidra. This Fair Ratio aims to reflect the P/E that might be expected given the company’s earnings growth profile, industry, profit margins, market cap and risk characteristics.

Because the Fair Ratio is tailored to Fluidra, it can be more informative than only lining the stock up against broad industry or peer averages. With the current P/E of 20.7x sitting below the 28.2x Fair Ratio, this check points to the stock looking undervalued on earnings.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 100 top founder-led companies.

Upgrade Your Decision Making: Choose your Fluidra Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so think of a Narrative as your own Fluidra story that connects what you believe about its business, such as demand for pools, margins and earnings in 2029, to a forecast and a Fair Value. It then compares that Fair Value with the current price to help you decide whether the stock fits your plan. This all happens within Simply Wall St's Community page where Narratives are refreshed when new news or earnings arrive. One investor might lean toward a higher fair value near €31.0 based on stronger growth and margin execution, while another might anchor to a lower figure around €19.2 that reflects more cautious assumptions about revenue, profit margins and the P/E multiple.

Do you think there's more to the story for Fluidra? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com